Manal F. Abdelmalek

Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis

National Institute of Diabetes and Digestive and Kidney Diseases · U01

PI · $571.6K · Duke University

Impact of Fructose on Metabolism, Energy Homeostasis and MR Biomarkers in NAFLD

National Institute of Diabetes and Digestive and Kidney Diseases · R01

PI · $913.9K · Duke University

Hyperinsulinemia and Insulin Resistance in Fatty Liver

National Institute of Diabetes and Digestive and Kidney Diseases · K23

Contact PI · $618K · Duke University

General Clinical Research Center

National Center for Research Resources · M01

Project lead · $153.5K · University of Florida

Statins for the Treatment of NASH

Principal investigator · Active not recruiting · Phase 2

Mayo Clinic

JKB-121 for the Treatment of Nonalcoholic Steatohepatitis

Principal investigator · Completed · Phase 2

Manal Abdelmalek

Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Disease

Principal investigator · Terminated · Phase 2

Manal F Abdelmalek

Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)

Principal investigator · Terminated · Phase 4

Duke University